BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7591425)

  • 1. Low-dose oral propylthiouracil in the treatment of plaque psoriasis.
    Elias AR; Barr RJ
    Int J Dermatol; 1995 Jul; 34(7):519-20. PubMed ID: 7591425
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of PTU on IL-12 and IL-10 in psoriasis.
    Elias AN; Nanda VS; Barr RJ
    J Drugs Dermatol; 2003 Dec; 2(6):645-8. PubMed ID: 14711144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Pandian R
    BMC Dermatol; 2004 Apr; 4():4. PubMed ID: 15119959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 expression in psoriatic lesions following therapy with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Barr RJ; Nanda VS
    Int J Dermatol; 2004 Dec; 43(12):889-92. PubMed ID: 15569009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Barr RJ
    BMC Dermatol; 2003 Jul; 3():3. PubMed ID: 12841851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propylthiouracil in psoriasis: results of an open trial.
    Elias AN; Goodman MM; Liem WH; Barr RJ
    J Am Acad Dermatol; 1993 Jul; 29(1):78-81. PubMed ID: 8315081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and safety of propylthiouracil in psoriasis: an open-label study.
    Gnanaraj P; Malligarjunan H; Dayalan H; Karthikeyan S; Narasimhan M
    Indian J Dermatol Venereol Leprol; 2011; 77(6):673-6. PubMed ID: 22016273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis.
    Elias AN; Dangaran K; Barr RJ; Rohan MK; Goodman MM
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):455-8. PubMed ID: 8077472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced apoptosis in psoriatic plaques after treatment with propylthiouracil.
    Elias AN; Barr RJ
    Eur J Dermatol; 2007; 17(4):353-4. PubMed ID: 17540660
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of orally administered antithyroid thioureylenes on PCNA and P53 expression in psoriatic lesions.
    Elias AN; Barr RJ; Rohan MK; Dangaran K
    Int J Dermatol; 1995 Apr; 34(4):280-3. PubMed ID: 7790147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis.
    Gnanaraj P; Dayalan H; Elango T; Malligarjunan H; Raghavan V; Rao R
    Int J Dermatol; 2015 Mar; 54(3):302-6. PubMed ID: 25267471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral propylthiouracil for the treatment of resistant plaque psoriasis.
    Chowdhury MM; Marks R
    J Dermatolog Treat; 2001 Jun; 12(2):81-5. PubMed ID: 12243663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmar skin lesions reversed by propylthiouracil therapy.
    Malani AK
    Am J Ther; 2006; 13(4):376-7. PubMed ID: 16858175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotoxic hepatitis.
    Barzilay-Yoseph L; Shabun A; Shilo L; Hadary R; Nabriski D; Kitay-Cohen Y
    Isr Med Assoc J; 2011 Jul; 13(7):448-50. PubMed ID: 21838194
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of antithyroid medication on the flow-volume loop in patients with hyperthyroidism.
    Arbak P; Bicik Z; Safak A; Cinar Y; Ulger F
    Tuberk Toraks; 2004; 52(3):243-7. PubMed ID: 15351937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis.
    Elias AN; Goodman MM; Rohan MK
    Int J Dermatol; 1993 Jul; 32(7):537-40. PubMed ID: 8340196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propylthiouracil on intestinal transit time and symptoms in hyperthyroid patients.
    Papa A; Cammarota G; Tursi A; Certo M; Montalto M; Capelli G; de Rosa G; Cuoco L; Fedeli G; Gasbarrini G
    Hepatogastroenterology; 1997; 44(14):426-9. PubMed ID: 9164513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and short-term effect of antithyroid agents on hyperthyroidism patients coexisting with viral hepatitis].
    Jiang T; Luo KZ; Zhang YH; Luo HY; Liang J; Liu M
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):59-60. PubMed ID: 20128972
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithyroid drugs in practice.
    Vanderlaan WP
    Mayo Clin Proc; 1972 Dec; 47(12):962-5. PubMed ID: 4117991
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum ICAM-1 concentrations in patients with psoriasis treated with antithyroid thioureylenes.
    Elias AN; Goodman MM; Rohan MK
    Clin Exp Dermatol; 1993 Nov; 18(6):526-9. PubMed ID: 7902785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.